• Fluconazole, Serum
  • Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
  • Toxoplasma gondii, Molecular Detection, PCR
  • Calcitonin (Thyrocalcitonin)
  • Amyloid Beta Protein Ratio 1-42/1-40, Spinal Fluid
  • Alternaria tenuis, IgE
  • Legionella pneumophilia antigen, DFA
  • Porphyrins, Whole Blood
  • UBE3A Gene Mutation Analysis, Angelman Syndrome, Blood
  • HER2/neu (ERBB2), IHC, Semi-Quantitative, Other Tissue
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncotype DX, Prostate Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncotype DX, Prostate Cancer
Medical Test

Turnaround Time
Access to Oncotype DX, Prostate Cancer is restricted.
Loading...